Related Experiment Video
Updated: May 16, 2026
09:04
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
Published on: May 11, 2020
Innovations in vaccine development: can regulatory authorities keep up?
Manon M J Cox1, Annelies Onraedt
1Protein Sciences Corporation, 1000 Research Parkway, Meriden, CT 06450, USA. manon.cox@proteinsciences.com
Expert Review of Vaccines
|November 27, 2012
Summary
This conference summarized key vaccine production challenges, including regulatory hurdles, manufacturing, and improving development timelines. Experts discussed advancements in vaccine development and biopharmaceutical manufacturing technologies.
Area of Science:
- Biotechnology
- Pharmaceutical Sciences
- Vaccinology
Background:
- The 3rd Vaccine Production Summit convened in San Francisco, CA, USA, from June 4-6, 2012.
- The summit addressed critical aspects of vaccine development and manufacturing.
- It ran parallel to the Biopharmaceutical Manufacturing conference, focusing on single-use applications.
Framework:
- Discussions covered regulatory challenges in vaccine development.
- Key themes included the use of adjuvants and vaccine manufacturing.
- Process development, quality by design (QbD), and vaccine stability were also central.
Implementation:
- Technology transfer in vaccine manufacturing was a significant topic.
- Strategies for improving vaccine development timelines were explored.
- The integration of quality by design principles was highlighted.
Implications:
- The summit provided insights into overcoming common obstacles in vaccine production.
- Attendees gained knowledge on optimizing manufacturing processes and regulatory compliance.
- The event fostered discussion on accelerating the delivery of essential vaccines.
Related Concept Videos
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:51Vaccinations
Overview
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.